glp 1 agonisten Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment Polyagonists Enable Increasingly Effective Treatment
Description
21 Antiarrhythmic Properties GLP-1RAs may lower the risk of AF, a common comorbidity in HF that worsens prognosis, by reducing the volume of epicardial fat, modulating calcium handling within cardiomyocytes and improving left atrial remodelling
September 9, 2024
36,61 However, exenatide ER is encapsulated in microspheres of medical-grade poly-(D,L-lactide-co-glycolide), which ensures the gradual and extended release of the drug (Figure 2B)
Secondary Research Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research
Role of Breast Cancer Resistance Protein (BCRP/ABCG2) in Cancer Drug Resistance
Its no secret that GLP-1 drugs like Ozempic and Wegovy are dominating headlines and prescriptions
